Generation of functional human hepatic endoderm from human induced pluripotent stem cells-Reference-Cited by-同舟云学术

Generation of functional human hepatic endoderm from human induced pluripotent stem cells

Published:2009-09-29 Issue:1 Volume:51 Page:329-335
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Sullivan Gareth J.,Hay David C.,Park In-Hyun,Fletcher Judy,Hannoun Zara,Payne Catherine M.,Dalgetty Donna,Black James R.,Ross James A.,Samuel Kay,Wang Gang,Daley George Q.,Lee Je-Hyuk,Church George M.,Forbes Stuart J.,Iredale John P.,Wilmut Ian

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.23335/fullpdf

Reference12 articles.

1. Reprogramming of human somatic cells to pluripotency with defined factors;Park;Nature,2008

2. Induction of pluripotent stem cells from adult human fibroblasts by defined factors;Takahashi;Cell,2007

3. Human induced pluripotent stem cells free of vector and transgene sequences;Yu;Science,2007

4. Progress and fuure challenges in stem cell-derived liver technologies;Dalgetty;Am J Physiol Gastrointest Liver Physiol,2009

5. Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling;Hay;Proc Natl Acad Sci U S A,2008

Cited by 381 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell Culture Models for Hepatitis B and D Viruses Infection: Old Challenges, New Developments and Future Strategies;Viruses;2024-04-30

2. Role of connexin 32 in the directional differentiation of induced pluripotent stem cells into hepatocytes;International Journal of Medical Sciences;2024

3. Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma;iScience;2023-12

4. Availability, Functionality, and Safety as well as Quality Control of Hepatocytes as Seeding Cells in Liver Regenerative Medicine: State of the Art and Challenges;Current Stem Cell Research & Therapy;2023-11

5. Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma;JHEP Reports;2023-09